The Grantee invites submission of qualifications and proposal data (collectively referred to as the “Proposal”) from interested U.S. firms that are qualified on the basis of experience and capability to execute a feasibility study (“Study”) for Mobihealthcare Limited (“Mobihealth” or “Grantee”) that would support the regional expansion of telehealth services (the “Project”) from the Federal Republic of Nigeria (the “Host Country”) to the Republic of Côte d’Ivoire, the Republic of Ghana, the Republic of Kenya, and the Arab Republic of Egypt (the “Target Countries”). The submission deadline is Friday, November 18, 2022, at 5:00 PM Nigeria local time with deadline for questions on Monday, November 7, 2022, 5:00PM, EST. The U.S. firm selected will be paid in U.S. dollars from a $998,000 grant to the Grantee from the U.S. Trade and Development Agency.’
About the Grantee
Mobihealth is a Nigerian subsidiary of Mobihealth International Ltd., a UK-domiciled telehealth provider. Mobihealth was founded by Dr. Funmi Adewara in 2017 and publicly rolled out its service offerings in 2020 In late 2020, Dr. Adewara was recognized by the World Bank for her work with Mobihealth and the development of its digital healthcare platform with the “Her World Bank SDGs&Her (Sustainable Development Goals) Award 2020.” The award was a part of a virtual award event carried out by the World Bank, in partnership with UNDP, UN Women, and the Wharton School Zicklin Center that recognizes women entrepreneurs. From 2020 to 2021, Mobihealth’s subscriber base in Nigeria grew from less than 4,000 to more than 34,000, and revenue increased from $83,500 to $814,400.
Project Background
Given increasing connectivity and growing investment in the health technology sector, several companies are offering telehealth solutions, including Mobihealth. Mobihealth has developed an integrated telemedicine and electronic medical records (“EMR”) platform that can be accessed in multiple ways. Mobihealth aims to extend its telehealth services from Nigeria, where it has an established presence, to underserved populations across the continent. This Project represents part of Mobihealth’s major growth initiative to reach and treat at least one million patients within ten years.
About the Study
The proposed Study would undertake the necessary research to inform Mobihealth’s potential investments and expansion of its solution and service to citizens in new markets. The Study would include a market analysis for each target country, including assessing general socioeconomic dynamics and demographics, the current supply of conventional healthcare facilities, existing telehealth programs, and the existing public and private insurance schemes available. Each market analysis would also include a “go-to-market” recommendation, such as a branding and customer acquisition strategy and pricing strategy. This analysis would also include recommendations on how and where to deploy the physical infrastructure in each country, and recommendations and engagement with potential U.S. sources of supply required for Project deployment. The Study would also include a legal and regulatory analysis for each market, which would be critical considerations for the deployment of the Project. The Study would also include an economic analysis, a financial analysis, preliminary environmental and social impact assessment, a development impact assessment, and engagement with potential U.S. suppliers. Importantly, the Study would also provide a Project implementation plan to guide the deployment across the four target countries.